64
Peritonitis in peritoneal dialysis patients Dr Cherelle Fitzclarence Renal GP July 2009

Peritonitis in PD Patients (ppt) 9mb

Embed Size (px)

DESCRIPTION

 

Citation preview

Page 1: Peritonitis in PD Patients (ppt) 9mb

Peritonitis in peritoneal dialysis patients

Dr Cherelle Fitzclarence

Renal GP

July 2009

Page 2: Peritonitis in PD Patients (ppt) 9mb

Overview

Peritoneal Dialysis - principles Anatomy Physiology Pathology Presentations Management Key points

www.health.com/

Page 3: Peritonitis in PD Patients (ppt) 9mb

Chronic Kidney Disease

Diagnosis

End Stage Kidney Disease

Diagnosis

DIALYSIS

HAEMODIALYSIS

PERITONEAL DIALYSIS

TRANSPLANTATION

PALLIATIVE CARESTAGE 1 & 2 Proteinuria plus

eGFR 60+

(to determine eGFR over 60, hand

calculate GFR using Cockcroft-Gault

formula)

STAGE 3

eGFR 30-59

ml/min

MODERATE

KIDNEY

DAMAGE

ProteinuriaCare plan

STAGE 5

eGFR <15

ml/min

FAILURE

STAGE 4

eGFR 15-29

ml/min

SEVERE

KIDNEY

DAMAGE

CKDCare plan

ESKDCare plan

GFR = (140 - Age) x wt (kg)

se creat (mmol/Lt)

Males = GFR x 1.23

Kidney Failure

SUPPORTIVE CARE APPROACH

Page 4: Peritonitis in PD Patients (ppt) 9mb

Peritoneal Dialysis

A form of renal replacement therapy for patients with end stage kidney disease

Endeavours to replace some of the functions of the kidney such as

Removing waste products Removing excess fluid Correcting acid/base imbalances Correcting electrolyte imbalances High maintenance form of therapy

requiring meticulous compliance and effort on part of patient

www.agingdiscodiva.com

Page 5: Peritonitis in PD Patients (ppt) 9mb

IDEAL BODY WEIGHTIBW

Normotensive (Good BP) 120/70 No signs and symptoms of overload or

dehydration Set by:

Home Training Staff Royal Perth Hospital Renal Doctor Dialysis Staff KSDC

Page 6: Peritonitis in PD Patients (ppt) 9mb

FLUID ASSESSMENT Blood pressure Weight Chest, SaO2, SOB Oedema

Ankles BackFacial

JVP Skin tugor Symptoms Nausea,

vomiting Diarrhoea Dizziness

Page 7: Peritonitis in PD Patients (ppt) 9mb

FLUID RESTRICTION

800 – 1000 mls per day Weigh patient (will be required daily

– SAME SCALES and document which ones)

In hospital, remove jug

Page 8: Peritonitis in PD Patients (ppt) 9mb
Page 9: Peritonitis in PD Patients (ppt) 9mb
Page 10: Peritonitis in PD Patients (ppt) 9mb
Page 11: Peritonitis in PD Patients (ppt) 9mb

Peritoneal Dialysis

Involves the passage of solutes and water across a membrane that separates two fluid containing compartments-blood and dialysate

During dialysis 3 transport processes occur simultaneously Diffusion Ultrafiltration Absorption

http://www.dialyse-45.net/int/info/techniques.htm

Page 12: Peritonitis in PD Patients (ppt) 9mb

Peritoneal Dialysis

2 types

CAPD – continuous ambulatory peritoneal dialysis

Involves on average 4 dwells per day of 4-8 hours of 2 – 2.5L each

APD – automated peritoneal dialysis Involves 3-10 exchanges overnight of varying

amounts Usually but not always a daytime dwell

Page 13: Peritonitis in PD Patients (ppt) 9mb

Peritoneal Dialysis

Anatomy Serosal membrane lining the gut Thought to be the same as the body surface

area – usually 1-2 m2 in adult 2 parts – visceral peritoneum lining the organs

(80% or the peritoneal surface area and the parietal peritoneum lining the walls of the abdominal cavity)

Peritoneal blood flow can’t be measured but indirectly estimated to be between 50-100mls/min

Page 14: Peritonitis in PD Patients (ppt) 9mb

Peritoneal Dialysis

Page 15: Peritonitis in PD Patients (ppt) 9mb

Horizontal disposition of the peritoneum in the lower part of the abdomen.

www.theodora.com/anatomy/the_abdomen.html

Page 16: Peritonitis in PD Patients (ppt) 9mb

Peritoneal Dialysis

Visceral peritoneum blood supply is from the superior mesenteric with venous drainage from the portal system

Parietal peritoneum blood supply is from the lumbar, intercostal and epigastric arteries while the venous drainage is via the IVC

Main lymphatic drainage is via stomata in the diaphragmatic peritoneum which drain into the right lymphatic duct

Page 17: Peritonitis in PD Patients (ppt) 9mb

Three pore model

Peritoneal capillary is the critical barrier to peritoneal transport

Movement of solute and water movement across the capillary is mediated by pores of three different sizes Large pores 20-40 nm – protein transport Small pores 4-6nm – small solutes eg urea,

creatinine, sodium, potassium, water Ultrapores (aquaporins) <0.8nm – transport of

water

Page 18: Peritonitis in PD Patients (ppt) 9mb

Three pore model of peritoneal transport

Kidney International ISSN: 0085-2538

EISSN: 1523-1755 © 2009 International Society of Nephrology

Page 19: Peritonitis in PD Patients (ppt) 9mb

Peritoneal Transport - Diffusion

Diffusion – uraemic solutes and potassium diffuse from peritoneal capillary blood into the dialysate. Glucose, lactate, bicarbonate and calcium diffuse in the opposite direction.

Diffusion depends on concentration gradient (maximal at the start), effective peritoneal surface area, intrinsic peritoneal membrane resistance, molecular weight of the solute (eg small molecules like urea, diffuse more rapidly than larger molecules such as creatinine)

Page 20: Peritonitis in PD Patients (ppt) 9mb

Diffusion

www.indiana.edu/.../lecture/lecnotes/diff.html

Page 21: Peritonitis in PD Patients (ppt) 9mb

Peritoneal Transport - Ultrafiltration

Occurs as a consequence of the osmotic gradient between the hypertonic dialysate and the relatively hypotonic peritoneal capillary blood

Driven by high concentration of glucose in dialysate Depends on;

concentration gradient of the osmotic agent (glucose) peritoneal surface area hydraulic conductance of the peritoneal membrane reflection coefficient for the osmotic agent (how effectively

the osmotic agent diffuses out of the dialysate into the peritoneal capillaries (0-1 is normal – the lower the value the faster the osmotic gradient is lost. Gluc is 0.3 as opposed to icodextrin which is close to 1)).

Hydrostatic pressure gradient – cap press around 20mm versus intraperitoneal pressure around 7mm Hg which favours ultrafiltration

Page 22: Peritonitis in PD Patients (ppt) 9mb

Ultrafiltration

http://www.dialysistips.com/principles.html

Page 23: Peritonitis in PD Patients (ppt) 9mb

Peritoneal Transport – Ultrafiltration 2

Depends on; Oncotic pressure gradient which acts to keep fluid in

blood, opposing ultrafiltration (low in hypoalbuminaemic patients so ultrafiltration tends to be high)

Sieving – occurs when solute moves along with water across a semipermeable membrane by convection but some of the solute is held back – sieved. The solute concentration in the ultrafiltrate that has passed through the membrane is lower than the source solution. Different solutes sieve differently ranging from 0 (complete sieving) to 1 (no sieving)

Other osmotic agents such as icodextrin with a large reflection coefficient so ultrafiltration is sustained

Page 24: Peritonitis in PD Patients (ppt) 9mb

Ultrafiltration

http://www.advancedrenaleducation.com/PeritonealDialysis/Ultrafiltration/HowtoAchieveAdequatePDUF/tabid/229/Default.aspx

Page 25: Peritonitis in PD Patients (ppt) 9mb

Peritoneal Transport – Fluid Absorption Occurs via the lymphatics at constant rate Typical values for peritoneal fluid absorption

are 1-2 mls/minute Affected by intraperitoneal hydrostatic

pressure Effectiveness of lymphatics

http://www.fmc-ag.com/gb_2006/en/05/glossar.html

Page 26: Peritonitis in PD Patients (ppt) 9mb

Peritonitis

Peritoneal Dialysis is a great form of renal replacement therapy

Peritonitis is a significant complication Incidence peritonitis episodes varies from 1/9

patient-months to 1/53 patient-months (Grunberg 2005; Kawaguchi 1999)

Our figures pending but are likely to be on the lower end of the scale

Page 27: Peritonitis in PD Patients (ppt) 9mb

Peritonitis in PD pts

Risk Factors Diabetes Non caucasian Obesity Temperate climate Depression Possibly the peritoneal dialysis

modality but not proven (Huang 2001; Oo 2005).

http://www.diabetesandrelatedhealthissues.com/

Page 28: Peritonitis in PD Patients (ppt) 9mb

Peritonitis in PD pts

Significant morbidity Some mortality - It is estimated that PD-

associated peritonitis results in death in 6% of affected patients (Troidle 2006).

gymsoap.com

Page 30: Peritonitis in PD Patients (ppt) 9mb

Pathogenesis

1. Potential routes of infection Intraluminal – improper technique; access to

bacteria via the catheter lumen Periluminal – bacteria present on skin surface

enter the peritoneal cavity via the catheter tract

Transmural – bacteria of intestinal origin migrate through the bowel wall

Haematogenous – peritoneum seeded via the blood stream

Transvaginal - ??

Page 31: Peritonitis in PD Patients (ppt) 9mb

Pathogenesis

2. Bacteria laden plaque – the intraperitoneal portion of the catheter is covered with a bacteria laden plaque - ? Role in pathogenesis of peritonitis

3. Host defences – peritoneal leucocytes critical in combating bacteria that have entered the peritoneum. Affected by A. dialysis solution and ph – hypertonic solution

inhibits activity B. Calcium levels – low calcium in dialysate inhibits

activity Peritoneal IgG levels – low levels inhibit activity HIV – little known effect

Page 33: Peritonitis in PD Patients (ppt) 9mb

Diagnosis

2 of the following 3 conditions Symptoms and signs of peritoneal

inflammation (pain, tenderness, guarding, rebound)

Cloudy peritoneal fluid with increased white cell count (specifically neutrophils)

Demonstration of bacteria on gram stain or culture

Page 34: Peritonitis in PD Patients (ppt) 9mb

Diagnosis – symptoms and signs

Abdo pain most common but in a PD pt suspect peritonitis if general malaise, nausea, vomiting or diarrhoea Don’t be blinded by the PD These pts get other pathology EG. Strangulated hernia, withdrawal from

steroids (if they stop taking meds suddenly and they happen to be on steroids), ruptured viscus, ulcers, perforations etc

EXAMINE THE PATIENT

Page 35: Peritonitis in PD Patients (ppt) 9mb

Diagnosis – symptoms and signs

PercentageSymptoms

Abdo pain 95

Nausea and vomiting 30

Fever 30

Chills 20

Constipation or diarrhoea 15

Signs

Cloudy peritoneal fluid 99

Abdo tenderness 80

Rebound tenderness 10-50

Increased temperature 33

Blood leucocytosis 25

CRP 100 but can be delayed

Daugirdas JT et al 2007 p 419

Page 36: Peritonitis in PD Patients (ppt) 9mb

Diagnosis – peritoneal fluid

Cloudiness – when cell count greater than 100 x 106

Normal is around 10x106 but always less than 50x106

Mostly cloudiness means peritonitis but be aware of other causes such as fibrin, blood, malignancy, chyle

Don’t write peritonitis off as a diagnosis if everything else fits but the fluid is relatively clear – the changes can lag

Must get a WCC (peritoneal fluid) with specific neutrophil count. Neutrophils required as the total number of white cells can vary according to whether patient dry or wet etc. Normally predominant cells are mononuclears and neutrophils are usually less than 15% of total white cell count

Be aware of mimickers such as PID, ovulation, recent pelvic examination which may affect the cell counts in the peritoneal fluid

Page 37: Peritonitis in PD Patients (ppt) 9mb

Peritoneal fluid culture

Send the whole bag Label it (preferable with texta – label can sweat off) Let the lab know it is coming Ask for urgent gram stain and cell count and ask this

to be telephoned to you. Be aware that the gram stain may be negative in 50% of cases of subsequent culture proven peritonitis

Also ask for M/C/S and fungal cultures Follow up the culture Do a full septic workup each time – including blood

cultures

Page 38: Peritonitis in PD Patients (ppt) 9mb

Peritonitis

Common things occur commonly and peritonitis is unfortunately common in our population of PD patients

BUT Don’t lose sight of the bigger picture and

these patients can suffer from any other pathology – always keep an open mind

Page 39: Peritonitis in PD Patients (ppt) 9mb

Peritonitis Management

Broad spectrum coverage Vancomycin (2.5g if more than 60kg / 2 g if 60kg or

less) Gentamicin (200mg if more than 60kg / 140mg if 60kg

or less) IP is better than IV (confirmed on large Cochrane

review April 2009) Await culture. If gram positive, then repeat the vanc

dose in 1 week. If gram negative then usually ceftriaxone 1g intraperitoneally daily for 14 days Things to note; if pseudomonas tube is very often lost.

May need to consider adding a second antibiotic such as daily ciprofloxacin

Page 40: Peritonitis in PD Patients (ppt) 9mb

Initial symptoms may include; diarrhoea, vomiting, nausea,

abdominal pain, mental confusion or feeling unwell

PERITONITIS MANAGEMENT

COLLECT DRAINED BAG *See additional resources (pink section) for drainage instructions

* Send entire bag for urgent MC&S (including WCC differential) and Fungal elements. **** Must ‘cc’ KRSS ****

Intraperitoneal (IP) Antibiotics (see Procedures)

Give BOTH Gentamycin – 160mgs if 60kgs or less(gram –ve organisms) 200mg if > 60kgsAND Vancomycin - 2gms if 60kgs or less(gram +ve organisms) 2.5grams if > 60kgs

Give both in a 2L 2.3% bagDwell in the abdomen for minimum 6 hours(Consult microbiologist if Vanc or Gent allergy)

must be able to read newspaper print through the bag

LOOK FOR OTHER CAUSESCall PD Coordinator or Renal GP

ATTENTION: Vanc and Gent provide some coverage while awaiting sensitivities. ****Further antibiotics WILL be required ****If Staph/gram +ve, give IP Vancomicin again on Day 7If gram negative, refer to sensitivities, but usually 14 days of IP Ceftriaxone 1gm

YOU MUST follow up the MC & S 48 hours after initial IP treatment. A WCC > 100 confirms peritonitis.If the patient is not improving within 24 hrs, or any other concerns, contact PD coordinator

CLEAR BAG CLOUDY BAG

Page 41: Peritonitis in PD Patients (ppt) 9mb

Peritonitis Mx

CAPD/APD Drain abdomen and send bag off with path

request as above Change the transfer set completely following

usual aseptic techniques Load 2.3% 2 litre dialysate bag (use 1.5% bag

if patient hypotensive) with Vancomycin and Gentamicin as per above guideline

Infuse bag into peritoneum 6 hour dwell

Page 42: Peritonitis in PD Patients (ppt) 9mb

Peritonitis – fungal infection

If fungal organisms are seen on gram stain, or cultured, it is unlikely you will be able to save the tube

Once the tube is colonized, the only cure is removal of tube, peritoneal rest (pt on Haemodialysis for a few months) and then start from scratch

Page 43: Peritonitis in PD Patients (ppt) 9mb

Peritonitis

If you think that the patient has peritonitis but you think they have life threatening sepsis eg hypotension, tachycardia, fever (or no fever as may not be able to mount an immune response), altered conscious state etc, your patient is likely to require IV broad spectrum antibiotics. Ring the microbiologist on call. Don’t wait to get IP regime in. That can go in while you are making calls and obtaining results.

Antibiotics must be given within 1 hour of presentation – it is an emergency.

I usually ring SCGH as they maintain a 24 hour consultant micro roster 93463333 but remember all our patients who require transfer must go to Royal Perth Hospital as they are under the RPH consultant

Page 45: Peritonitis in PD Patients (ppt) 9mb

Peritonitis

Additives to bags Vancomycin, aminoglycosides and

cephalosporins are safe to mix in the same bag

Aminoglycosides are incompatible with penicillins

Vancomycin is stable for 28 days in dialysate (normal room temp)

Cefazolin is stable for 8 days Gentamicin is stable for 14 days Heparin added decreases duration of stability

Page 46: Peritonitis in PD Patients (ppt) 9mb

Peritonitis

Often get formation of fibrin clots which increases risk of catheter block

May need to add 500units of heparin to 1 or 2 bags a day until fibrin clots decrease

Constipation is common – you may need to stop the calcium based phosphate binders temporarily but better off using aperients early and preventing the need to alter routine meds

Page 47: Peritonitis in PD Patients (ppt) 9mb

Peritonitis

Fluid regimes Depends whether patient is overloaded or

underloaded Can usually continue normal regime but tailor to

patient If BP low, use 1.5% bags x 4 a day If BP high use 2.3% bags, minimum of 4 a day Aim for BP 120/ APD pts can continue on APD or if needed can

convert temporarily to CAPD – in Broome with resources this should not be necessary

Page 48: Peritonitis in PD Patients (ppt) 9mb

Peritonitis

Can get changes in the permeability of the peritoneal membrane Permeability to water, glucose and proteins is

increased Rapid glucose absorption from the dialysis solution

reduces amount of ultrafiltration and can result in fluid overload

May need high glucose concentration dialysate with shorter dwells

Hyperglycaemia is common Protein loss is increased in peritonitis so patients will

need high protein supplements

Page 49: Peritonitis in PD Patients (ppt) 9mb

Peritonitis

Don’t forget secondary causes of peritonitis Perforated gastric or duodenal ulcer Pancreatitis Appendicitis Diverticulitis PID

Talk to the surgeon if you are not sure

Page 50: Peritonitis in PD Patients (ppt) 9mb

Peritonitis

You don’t necessarily have to admit the patient

Admission dictated by symptoms and distress and often social circumstances up here

blogs.southshorenow.ca/louise/ cms.ich.ucl.ac.uk/website/imagebank/images

Page 51: Peritonitis in PD Patients (ppt) 9mb

Peritonitis - bugs

Staph – Vancomycin and repeat in 1 week Patients should have nasal carriage treated with

mupirocin bd for 5 days and then once a week of bd for 5 days once a month

Gram Negs – IP Ceftriaxone for 2 weeks and consider repeating the dose of gentamicin after a week or adding oral ciprofloxacin to the regime Pseudomonas difficult to treat Sternotrophomonas – usually requires 2 antibiotics

and usually for 4 weeks Campylobacter not that common – responds to

gentamicin

Page 52: Peritonitis in PD Patients (ppt) 9mb

Peritonitis

Multiple organisms Have a high index of suspicion for secondary

peritonitis If not secondary peritonitis have 60% chance of curing

with appropriate antibiotics If one of the organisms is clostridium or bacteroides –

likely intra-abdominal abscess or perforated abdominal viscus but exclude appendicitis, perforated ulcer, pancreatitis and any other cause of secondary peritonitis

Occurrence of abdominal catastrophe in PD patient has a high mortality

Talk to the surgeon Add metronidazole Ship south

Page 53: Peritonitis in PD Patients (ppt) 9mb

Peritonitis

Culture negative disease If cell count less than 50 x 106…unlikely to

peritonitis If higher white cell count, then repeat empiric

therapy Make sure lab is doing cultures for AFB’s and

fungus If not improving consider legionella,

campylobacter, ureaplama, mycoplasma, enteroviruses, fungus, histoplasma capsulatum

Page 54: Peritonitis in PD Patients (ppt) 9mb

Peritonitis

Fungal peritonitis Predisposing factors

Prior antibiotic use especially if not full treatment Immunosuppressive therapy HIV Malnutrition Low albumin Diabetes

Page 55: Peritonitis in PD Patients (ppt) 9mb

Peritonitis

Fungal peritonitis We tend to try and save the tube by giving

antifungals but guidelines recommend prompt removal of catheter, conversion to haemodialysis for a few weeks and then start from scratch

Penetration of antifungals to peritoneum other than with IP administration, is poor

Page 56: Peritonitis in PD Patients (ppt) 9mb

Peritonitis

Refractory disease Defined as disease that is treated with

appropriate antibiotics for 5 days without improvement

Catheter removal necessary to reduce morbidity and preserve peritoneum

Increased with gram neg bugs

Page 57: Peritonitis in PD Patients (ppt) 9mb

Peritonitis

Relapsing disease Peritonitis with the same organism within 4 weeks of stopping

therapy Usually Staph epidermidis or a gram negative organism If pseudomonas or gram negatives, remove the catheter If staph, may be able to rescue with repeat vancomycin weekly

for a month or may be able to remove the tube and simultaneously insert a new tube (as opposed to any other organism where a 2 month peritoneal rest is required)

Sometimes can use urokinase to strip the biofilm (bacteria entrapped in fibrin in the peritoneal membrane) in relapsing disease – last resort but worth a go

Page 58: Peritonitis in PD Patients (ppt) 9mb

Peritonitis

20% of episodes temporally associated with exit site and tunnel infections (Piraino et al 2005)

Treat exit site infections if red and purulent Swab it Start Flucloxacillin empirically and change or

add ciprofloxacin if gram neg Exit sites are another whole topic

Page 60: Peritonitis in PD Patients (ppt) 9mb

Cochrane Review 2009 Implications for practice•

At the present time broad spectrum antibiotics should be initiated at the time a diagnosis of peritonitis is made. When choosing antibiotics the side-effect profile, local drug resistance patterns and previous antibiotic use and infection history in the individual concerned should be considered. In cases of recurrent peritonitis dialysis catheters should be removed rather than using intraperitoneal urokinase.•

Currently available evidence from RCTs is inadequate in many areas of clinical practice important in the management of PD-associated peritonitis. This is a limiting factor in the provision of definitive treatment guidelines.

Page 61: Peritonitis in PD Patients (ppt) 9mb

Cochrane Review 2009 Implications for research•

Further studies are required to establish the most effective treatment for peritoneal dialysis-associated peritonitis. An essential feature of such studies is inclusion of enough patients to ensure adequate power to assess meaningful long and short term outcomes. Short term outcomes should extend beyond whether cure is achieved without catheter removal, for example duration of systemic inflammation. Study of long-term outcomes should include permanent transfer to haemodialysis, development of ultrafiltration failure patient death and late recurrent episodes of peritonitis beyond four weeks from the original episode.• Specific interventions that would be of value include early versus late catheter removal. Studies designed to study infections due to specific organisms would also be valuable. An example is a study of glycopeptide versus cephalosporin therapy in peritonitis due to coagulase negative Staphylococcal species. The majority of studies have included patients on CAPD rather than APD hence studies designed to test the efficacy of antibiotics in APD are required. This is particularly applicable to studies of intermittent versus continuous dosing when cycler dwell times may well influence pharmacokinetics.• Future research should be conducted using standard definitions, with inclusion of information about factors that may influence the response to therapy such as prophylaxis regimens and dialysis solutions used. Current ISPD guidelines provide a comprehensive list of requirements for future studies that should be referred to when designing studies.

Page 62: Peritonitis in PD Patients (ppt) 9mb

Take home points

•Have a high index of suspicion

•Use the remote area manual

•Always let KRSS know of episode

•Copy all results to KRSS

•Don’t hesitate to ask if you are not sure – KRSS team, KRSS GP, Renal GP, Nephrologist

www.learningradiology.com

Page 63: Peritonitis in PD Patients (ppt) 9mb

Acknowledgements

Thanks to Daugirdas et al 2007 – Handbook of dialysis

http://mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005284/frame.html

Page 64: Peritonitis in PD Patients (ppt) 9mb

Thank you

Questions

[email protected]